Work

Anti-Tumor Activity of Single-Agent CCI-779 for Relapsed Mantle Cell Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.129.129

Authors: Thomas Witzig, Susan Geyer, Irene Ghobrial, David Inwards, Rafael Fonseca, Scott Kaufmann, Paul Kurtin, Joseph Colgan, William Morice, Steven Alberts, Muhammed Salim, Kendrith Rowland, Shaker Dakhil, Roscoe Morton, Philip Stella

Institutions: Mayo Clinic, Iowa Oncology Research Association, Michigan Cancer Research Consortium

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2578424755

FWCI: 1.69

Cites:

Cited by: 11

Related to: 10